Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-019455

Chief Medical Officer acquired 62,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones Jeffrey Alan Chief Medical Officer 2024-02-22 Grant or award +62,500 118,691 D
Derivatives
Jones Jeffrey Alan Chief Medical Officer 2024-02-22 Grant or award · Stock Option (Right to Buy) +125,000 125,000 D
Loading xslF345X05/ownership.xml…